Midodrine Hydrochloride Tablets — Class II drug recall D-0383-2026
Ongoing recall by The Harvard Drug Group LLC, reported 2026-03-11, distributed nationwide. Defective container; inadequately sealed blister packaging.
| Recall number | D-0383-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | The Harvard Drug Group LLC, Dublin, OH, United States |
| Recall initiated | 2026-02-17 |
| Classified | 2026-03-03 |
| Reported by FDA | 2026-03-11 |
| Distributed | Nationwide (US) |
| Quantity | 8,892 cartons |
| Reason classes | packaging |
| NDC | 00904-6817, 00904-6817-06, 00904-6817-61, 00904-6818, 00904-6818-06, 00904-6818-61, 00904-6819, 00904-6819-07 |
| Lot numbers | N02640 |
| Expiration dates | 2027-08 |
Product
Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.
Reason for recall
Defective container; inadequately sealed blister packaging.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0383-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.